ArcherDx, Inc.
ArcherDx, Inc., a leading player in the precision medicine industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2013, the company has rapidly established itself as a pioneer in genomic profiling and next-generation sequencing technologies, focusing on oncology and rare diseases. ArcherDx is renowned for its innovative products, including the Archer FusionPlex and Archer VariantPlex assays, which enable comprehensive genomic analysis with unparalleled accuracy and sensitivity. These offerings are distinguished by their ability to detect a wide range of genetic alterations, making them invaluable tools for personalised cancer treatment. With a strong market position, ArcherDx has achieved notable milestones, including strategic partnerships and collaborations that enhance its research capabilities and expand its global reach. The company continues to drive advancements in molecular diagnostics, solidifying its reputation as a trusted leader in the field.
DitchCarbon Score
How does ArcherDx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ArcherDx, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ArcherDx, Inc.'s reported carbon emissions
ArcherDx, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that ArcherDx may not yet have established a comprehensive framework for addressing its carbon footprint or climate impact. In the context of the biotechnology industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate change. However, without specific commitments or data, ArcherDx's position in this regard remains unclear. As the industry evolves, it is anticipated that ArcherDx may develop and disclose its climate strategies in alignment with broader environmental goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ArcherDx, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
